BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16001640)

  • 1. Decreased cell-mediated immune status in colorectal cancer patients with hepatic metastasis.
    Shimizu H; Ito H; Kimura F; Togawa A; Yoshidome H; Ohtsuka M; Kato A; Nukui Y; Miyazaki M
    Hepatogastroenterology; 2005; 52(64):1106-9. PubMed ID: 16001640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of acupuncture on the activity of the peripheral blood T lymphocyte subsets and NK cells in patients with colorectal cancer liver metastasis].
    Zhao CL; Peng LJ; Zhang ZL; Zhang T; Li HM
    Zhongguo Zhen Jiu; 2010 Jan; 30(1):10-2. PubMed ID: 20353106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of cancer using lymphocyte electrophoresis (3): Electrophoretic mobility, interleukin 1 and prostaglandin E2 productions of monocytes in peripheral blood of cancer patients].
    Shimizu M; Sekine K; Iwaguchi T; Kataoka T; Mori T
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):639-43. PubMed ID: 2321984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
    Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
    Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
    Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
    Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoresponsiveness of cancer patients: effect of blood transfusion and immune reactivity of tumor infiltrating lymphocytes.
    Quintiliani L; Iudicone P; Di Girolamo M; Buzzonetti A; Guglielmetti M; Lapponi P; Traietti P; Monno D; Giuliani E
    Cancer Detect Prev; 1995; 19(6):518-26. PubMed ID: 8925521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor doubling time and local immune response to hepatic metastases from colorectal cancer.
    Kito A; Tanaka K; Fujimaki H; Nakazawa M; Togo S; Minami M; Shimada H
    J Surg Oncol; 2007 Nov; 96(6):525-33. PubMed ID: 17654526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of tumor burden on differentiation of T lymphocytes in the peripheral blood of patients with colorectal cancer].
    Cui M; Wang S; Ye YJ; Cui ZR; Ke Y
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):16-9. PubMed ID: 17403305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in hepatic immunoregulatory cytokines in patients with metastatic colorectal carcinoma: implications for hepatic anti-tumour immunity.
    Kelly AM; Golden-Mason L; Traynor O; Geoghegan J; McEntee G; Hegarty JE; O'Farrelly C
    Cytokine; 2006 Aug; 35(3-4):171-9. PubMed ID: 16971136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antioxidant status of patients with primary colorectal cancer and liver metastases of colorectal cancer].
    Czeczot H; Skrzycki M; Podsiad M; Gawryszewska E; Nyckowski P; Porembska Z
    Pol Merkur Lekarski; 2005 Jan; 18(103):58-61. PubMed ID: 15859549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
    Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
    Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on correlation of hepatic metastasis of colorectal cancer to vascular endothelial growth factor, angiopoietin-2, and fibronectin].
    Liang XY; Wang T; Yang XD; Qiu YJ; Zhu LW; Wang PZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jan; 8(1):20-3. PubMed ID: 16148991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
    Romano F; Uggeri F; Crippa S; Di Stefano G; Scotti M; Scaini A; Caprotti R; Uggeri F
    J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes.
    Walmesley AJ; Zweiri J; Christmas SE; Watson AJ
    J Immunother; 2007 Sep; 30(6):614-23. PubMed ID: 17667525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
    Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
    Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
    Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
    Maccalli C; Di Cristanziano V; Fodale V; Corsi D; D'Agostino G; Petrangeli V; Laurenti L; Guida S; Mazzocchi A; Arienti F; Perrone MP; Castelli C; Rivoltini L; Zagonel V; Tartaglia M; Parmiani G; Belardelli F
    Clin Cancer Res; 2008 Nov; 14(22):7292-303. PubMed ID: 18974390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer.
    Chen X; Hu ZP; Yang XX; Huang M; Gao Y; Tang W; Chan SY; Dai X; Ye J; Ho PC; Duan W; Yang HY; Zhu YZ; Zhou SF
    Int Immunopharmacol; 2006 Mar; 6(3):499-508. PubMed ID: 16428086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.